Corbus Pharmaceuticals Holdings Inc.

(CRBP) Trade

By |

Profile

Corbus Pharmaceuticals Holdings Inc is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Contact Information

Website: www.corbuspharma.com
Email: ir@corbuspharma.com
Main Phone: +1 617 963-0100
Address: 500 River Ridge Drive
Address 2: Second Floor
State: MA
City / Town: Norwood
Country: US
Postal Code: 02062

Issuer Information

Exchange: NSD
CEO: Yuval Cohen
Employees: 141
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More

Profile

Corbus Pharmaceuticals Holdings Inc is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Contact Information

Website: www.corbuspharma.com
Email: ir@corbuspharma.com
Main Phone: +1 617 963-0100
Address: 500 River Ridge Drive
Address 2: Second Floor
State: MA
City / Town: Norwood
Country: US
Postal Code: 02062

Issuer Information

Exchange: NSD
CEO: Yuval Cohen
Employees: 141
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More
$ 2.18 $ -0.13 (-5.63%)
Last Price 2.18 Change $ -0.13 Change % -5.63 Tick N/A
Bid 2.18 Bid Size 200.00 Ask 2.20 Ask Size 200.00
Open 2.29 High 2.41 Low 2.14 Prev Close 2.31
Last Trade Volume 7.3 mi 52 Wk Hi 9.78 52 Wk Low 0.92
Market Cap 183.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 84,037,239.00 EPS (TTM) -1.79 PE Ratio -1.40 Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 32 32 32 32
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 24.67 24.67 24.67 24.67
Standard Deviation 6.43 6.43 6.43 6.43
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 5 5 5
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.17 1.17 1.17

© 2021 Equities News | Equities.com, Inc.

* All dates and time are being displayed in Eastern Standard Time (EST).